end stage kidney disease
Conditions
Interventions
group ICO:Icodextrin peritoneal dialysis fluid
control group GLU :glucose PD fluid
Sponsors
Shanghai East Hospital (East Hospital Affiliated to Tongji University)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years (including 18 and 75 years old), gender, ethnicity, dialysis age is not limited; 2. CAPD and stable dialysis for more than 3 months; 3. Life expectancy greater than 1 year; 4. The patient signs an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Less than 3 months of peritoneal dialysis; 2. Received automated peritoneal dialysis and received icodextrin solution prior to enrollment; 3. Patients with advanced malignant tumors, liver cirrhosis and severe liver insufficiency, severe infection, active tuberculosis, acute myocardial infarction within three months before entering the study, history of major surgical trauma within three months, peritonitis within three months, etc.; 4. Have hepatitis B or HIV seropositive, or are receiving immunosuppressive medications; 5. From hemodialysis and kidney transplantation to abdominal dialysis; 6. Hypersensitivity to icodextrin dialysate; 7. The patient refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival analysis;major advance cardiac event; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bioimpedance body composition analysis; | — |
Countries
China
Contacts
Public ContactLiu Na
Shanghai East Hospital (East Hospital Affiliated to Tongji University)
Outcome results
None listed